Delivery Order SPE2DR25D2007-SPE2DR26FM25A
- Not listed
- The Defense Logistics Agency awarded a $1,497.81 firm fixed-price delivery order to AmerisourceBergen Drug Corp for MYFEMBREE (a combined hormonal contraceptive tablet available in 40 mg, 1 mg, and 0.5 mg formulations, 28-count packaging) on December 4, 2025, with completion expected by December 5, 2025. This non-set-aside contract will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $5,618.42 to AmerisourceBergen Drug Corp for MYFEMBREE pharmaceutical products (40 mg, 1 mg, and 0.5 mg tablets, 28-count supply). This firm fixed-price delivery order, issued on November 24, 2025, represents a non-competitive set-aside award and is due for completion by November 25, 2025. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency (DLA) awarded a $4,543.25 firm fixed-price delivery order to AmerisourceBergen Drug Corp for MYFEMBREE pharmaceutical products (40 mg, 1 mg, and 0.5 mg tablets in a 28-count package) on October 30, 2025, with an ultimate completion date of October 31, 2025. The contract was competitively awarded with no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a $2,233.71 firm fixed-price delivery order to AmerisourceBergen Drug Corp for MYFEMBREE 40 MG-1 MG-0.5 MG tablets (28-count) with an ultimate completion date of June 2, 2025. This non-set-aside award was made competitively and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The place of performance is the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,547.13 to AmerisourceBergen Drug Corp for MYFEMBREE 40 MG-1 MG-0.5 MG tablets (28-count), a pharmaceutical product to be delivered to the company's facility in Conshohocken, Pennsylvania. This firm fixed-price delivery order, issued on June 2, 2025, with an ultimate completion date of June 3, 2025, represents a non-competitive award under an existing contract vehicle. The award reflects routine pharmaceutical supply procurement...
- The Defense Logistics Agency awarded a $3,364.37 firm fixed-price delivery order to AmerisourceBergen Drug Corp for pharmaceutical products on August 22, 2025, with an ultimate completion date of August 25, 2025. The delivery order covers Myfembree 40 mg–1 mg–0.5 mg tablets in a 28-day supply, a hormonal contraceptive medication. This is a non-set-aside competitive award issued against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order valued at $2,991.21 to AmerisourceBergen Drug Corp for the supply of Myfembree (40 mg-1 mg-0.5 mg tablets, 28-count packages) on December 2, 2025, with completion scheduled for December 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating the award resulted from open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- This delivery order, awarded on April 24, 2025, represents a $3,377.60 firm fixed-price purchase of MYFEMBREE (ethinyl estradiol/norethindrone acetate/ferrous fumarate) tablets in multiple strengths from AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The award was made by the Defense Logistics Agency under a non-competitive, non-set-aside procurement with an ultimate completion date of April 25, 2025. This delivery order is issued...
- The Defense Logistics Agency Troop Support Medical awarded a $1,530.93 delivery order to Amerisourcebergen Drug Corporation for the product "MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S." The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is September 5-6, 2023. This firm fixed price order was placed under an indefinite-delivery/indefinite-quantity contract vehicle, though details of the underlying contract were not...
- The Defense Logistics Agency awarded a delivery order valued at $8,499.46 to AmerisourceBergen Drug Corp for the supply of Myfembree (40 mg, 1 mg, 0.5 mg tablets, 28-count package) on April 25, 2025, with an ultimate completion date of April 28, 2025. This competitively awarded, firm fixed-price delivery order was issued under a non-set-aside procurement and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical delivery...
- SPE2DR25D2007Indefinite Delivery Contract
- SPE2DR25D2007-SPE2DR26FM25ADelivery Order
The Defense Logistics Agency awarded a $1,899.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for MYFEMBREE pharmaceutical products (40 mg, 1 mg, and 0.5 mg tablets, 28-count package) with a completion date of December 11, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion and extending through December 2026. The delivery will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive portfolio of federal contract awards with DLA demonstrates its capability to supply a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains. This specific delivery order for MYFEMBREE contraceptive medication supports the company's role in providing essential medications to Defense Health Agency beneficiaries and other federal healthcare systems through its established pharmaceutical supply framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 12/9/25 |